Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 41.67
-1.31 (-3.05%)
Aug 21, 2026, 3:04 PM CST
SHE:300049 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 11,001 | 18,657 | 8,401 | 11,466 | 6,426 | 3,768 | |
Market Cap Growth | -41.77% | 122.08% | -26.73% | 78.43% | 70.55% | 80.15% |
Enterprise Value | 10,830 | 18,454 | 8,244 | 11,224 | 6,210 | 3,561 |
Last Close Price | 41.67 | 70.18 | 31.44 | 43.45 | 24.16 | 14.54 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 70.71 | 121.08 | 74.16 | 112.90 | 65.65 | 39.47 |
Forward PE | 37.88 | 69.97 | 34.56 | 64.69 | 29.24 | 29.24 |
PS Ratio | 6.77 | 11.69 | 6.23 | 9.94 | 6.37 | 4.19 |
PB Ratio | 4.43 | 7.55 | 3.95 | 6.21 | 3.52 | 2.09 |
P/TBV Ratio | 9.01 | 15.35 | 8.53 | 11.83 | 6.48 | 3.90 |
P/FCF Ratio | 59.33 | 114.80 | 3440.21 | 99.14 | 65.12 | 26.36 |
P/OCF Ratio | 29.90 | 53.07 | 37.94 | 37.61 | 33.92 | 16.93 |
PEG Ratio | - | 1.62 | 1.62 | 1.62 | 1.62 | 1.62 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 6.66 | 11.57 | 6.11 | 9.73 | 6.16 | 3.96 |
EV/EBITDA Ratio | 21.44 | 38.58 | 22.96 | 36.50 | 26.27 | 16.10 |
EV/EBIT Ratio | 26.94 | 46.19 | 28.74 | 46.70 | 34.81 | 21.27 |
EV/FCF Ratio | 58.42 | 113.55 | 3376.06 | 97.05 | 62.93 | 24.91 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.06 |
Debt / EBITDA Ratio | 0.16 | 0.19 | 0.20 | 0.18 | 0.22 | 0.46 |
Debt / FCF Ratio | 0.43 | 0.57 | 31.29 | 0.51 | 0.56 | 0.76 |
Net Debt / Equity Ratio | -0.27 | -0.26 | -0.30 | -0.29 | -0.31 | -0.28 |
Net Debt / EBITDA Ratio | -1.39 | -1.34 | -1.80 | -1.77 | -2.37 | -2.31 |
Net Debt / FCF Ratio | -3.61 | -3.94 | -265.32 | -4.71 | -5.67 | -3.57 |
Asset Turnover | 0.50 | 0.49 | 0.47 | 0.45 | 0.40 | 0.37 |
Inventory Turnover | 2.84 | 2.76 | 2.91 | 2.95 | 2.71 | 2.33 |
Quick Ratio | 2.86 | 2.73 | 3.56 | 3.66 | 4.63 | 3.67 |
Current Ratio | 3.44 | 3.20 | 4.12 | 4.21 | 5.20 | 4.18 |
Return on Equity (ROE) | 11.52% | 11.24% | 9.86% | 9.64% | 8.01% | 8.65% |
Return on Assets (ROA) | 7.73% | 7.69% | 6.28% | 5.81% | 4.42% | 4.35% |
Return on Invested Capital (ROIC) | 16.32% | 17.79% | 14.93% | 14.08% | 10.57% | 10.39% |
Return on Capital Employed (ROCE) | 13.50% | 13.50% | 10.70% | 10.20% | 7.80% | 7.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.43% | 0.83% | 1.35% | 0.89% | 1.52% | 2.53% |
FCF Yield | 1.69% | 0.87% | 0.03% | 1.01% | 1.54% | 3.79% |
Dividend Yield | 0.03% | 0.02% | - | - | 0.83% | - |
Payout Ratio | 1.47% | 1.48% | 1.94% | 52.60% | 72.95% | 2.04% |
Buyback Yield / Dilution | -1.54% | -0.84% | -0.15% | 0.01% | -1.30% | -1.31% |
Total Shareholder Return | -1.51% | -0.82% | -0.15% | 0.01% | -0.47% | -1.31% |